Immunotherapy for Pancreatic Cancer
A physician-evaluated, immune-based approach for patients diagnosed with pancreatic cancer — including advanced and metastatic cases.
Pancreatic Cancer: Overview
Pancreatic cancer is often diagnosed at advanced stages and is commonly treated with surgery, chemotherapy, radiation, or targeted therapies. Many patients continue looking for additional options — especially when the disease is advanced, metastatic, or when response to conventional treatment is limited.
NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.
"Pancreatic tumors are known to create a highly immunosuppressive environment. Strategies that work with the immune system — not around it — are among the most meaningful options to explore."
Giostar Medical Team
Why early action is Critical
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers — time is a critical factor.
cancer death ranking
#3
leading cause of cancer-related death in the United States.
5-year survival rate
<13%
largely due to late-stage diagnosis. (American Cancer Society)
Why timely evaluation matters
Late-stage diagnosis delays
Limited intervention windows
Nutritional and digestive function
Energy and physical capacity
Because symptoms often appear late, many patients are diagnosed when the disease has already progressed. Delaying evaluation may significantly limit available treatment options.
Why Consider Cellular Immunotherapy?
Natural Killer cells play a key role in detecting and eliminating abnormal cells. This is particularly relevant in pancreatic cancer, where tumors are known to create a highly immunosuppressive environment that limits the effectiveness of many treatments.
In breast cancer, particularly in recurrent or advanced cases, immune-based approaches may help support ongoing disease control.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Support immune surveillance
Help the immune system recognize abnormal cells
Provide a systemic, whole-body immune approach
Complement a broader treatment strategy when medically appropriate
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with pancreatic cancer
Have advanced, recurrent, or metastatic disease
Are exploring complementary or integrative treatment options
Have not responded as expected to conventional treatment
Want to support immune function during or after treatment
Are seeking a less invasive cellular therapy option
Every case is individually reviewed by our physician team to determine eligibility
Not all pancreatic cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A Comprehensive Approach
Enhance immune surveillance
Support identification and elimination of abnormal cells
Complement conventional treatments
Provide a systemic, whole-body approach
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.